The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)
Condition: Osteoporosis Intervention: Drug: risedronate (including placebo) Sponsors: University of Pittsburgh; Procter and Gamble; Aventis Pharmaceuticals Completed - verified August 2011